Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432783 · ClinicalTrials.gov registry record
A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 45
- Enrollment target
NCT00432783 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 45 participants.
The verdict
NCT00432783 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Pharmacologic boosting of protease inhibitors with ritonavir has become standard practice in antiretroviral therapy. Patients are instructed to take ritonavir at the same time as its accompanying protease inhibitor. However, ritonavir is unpopular with many patients because of its large size and because of the recommended need for refrigeration. This study will test the hypothesis that adherence to ritonavir is inferior to adherence to its accompanying protease inhibitor in patients receiving such therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432783
The ClinicalTrials.gov registry entry for NCT00432783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00432783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432783 about?
NCT00432783 is a clinical study titled "A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor". Pharmacologic boosting of protease inhibitors with ritonavir has become standard practice in antiretroviral therapy. Patients are instructed to take ritonavir at the same time as its accompanying protease inhibitor. However, ritonavir is unpopular with many patients because of its large size and bec...
What is the current status of trial NCT00432783?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2006-06. Estimated completion is 2007-08.
Who is sponsoring clinical trial NCT00432783?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.